Health Care · Medical Care Facilities

LifeStance Health Group, Inc. LFST

$10.74-0.12 (-1.10%)delayed quote · as of 2026-07-31 06:23 UTC

Open LFST in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$4.1B

Previous close

$10.86

Volume

1.9M

52-week range

$3.74 – $11.76

Verdictconfidence 88% · high

Growth and Health stand out; value flashes caution.

3 of 5 dimensions score well; value flashes caution. Momentum not scored — not enough data.

Value402/5 checks

Growth1005/5 checks

Quality603/5 checks

Health1005/5 checks

Momentum—2/2 checks

Fair-value estimate $5.03 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 114% above it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

179.0

P/E FWD

27.4

EV/EBITDA TTM

47.8

PEG

1.15

FCF yield TTM

3.5%

Growth

Revenue 3y

+18.3%/yr

Revenue YoY

+13.9%

Expected EPS

+553.4%

Quality

Piotroski F

8 / 9

ROIC

6.5%

Gross margin

—

Health

Altman Z

3.86

Current ratio

1.65

Debt/equity

0.18

Momentum

vs 50-day

—

vs 200-day

—

52-wk range

87%

FY 2025: revenue $1.4B · net income $9.7M · free cash flow $110.0M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-31 06:23 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading LFST’s filed statements…

Continue with LFST in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.